Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Accounts Payables (2020 - 2025)

Historic Accounts Payables for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $11.9 million.

  • GoHealth's Accounts Payables fell 2245.34% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 2245.34%. This contributed to the annual value of $14.6 million for FY2024, which is 1758.83% down from last year.
  • Latest data reveals that GoHealth reported Accounts Payables of $11.9 million as of Q3 2025, which was down 2245.34% from $19.9 million recorded in Q2 2025.
  • GoHealth's Accounts Payables' 5-year high stood at $39.8 million during Q4 2021, with a 5-year trough of $5.8 million in Q1 2024.
  • Its 5-year average for Accounts Payables is $15.8 million, with a median of $14.6 million in 2022.
  • In the last 5 years, GoHealth's Accounts Payables soared by 35623.5% in 2021 and then crashed by 6198.08% in 2022.
  • GoHealth's Accounts Payables (Quarter) stood at $39.8 million in 2021, then tumbled by 61.98% to $15.1 million in 2022, then grew by 16.88% to $17.7 million in 2023, then decreased by 17.59% to $14.6 million in 2024, then decreased by 18.76% to $11.9 million in 2025.
  • Its Accounts Payables was $11.9 million in Q3 2025, compared to $19.9 million in Q2 2025 and $20.3 million in Q1 2025.